Welcome to Probiodrug
Pioneering Therapeutics for Common Degenerative Disorders
Probiodrug AG is a biopharmaceutical company focused on the development of innovative oral drugs for the treatment of major age related diseases.
Latest News
2012-01-06
Probiodrug AG to Present at the 30th JP Morgan Annual Healthcare Conference … more
2012-01-04
Probiodrug AG raises additional €15 Million to advance its clinical program … more
2011-11-14
Probiodrug Announces Top-Line Results of the First Clinical Study of PQ912 for Treatment of Alzheimer’s Disease … more